SCHEMBL28903935

SCHEMBL28903935

COc1nc(C)ccc1-c1cnn2ccc(N(C)CCCOC(C)(C)C)nc12

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMPD3 Q9NY59 4/20 0.39
▸ CSNK2A1 P68400 2/20 0.35
▸ CSNK2A2 P19784 1/20 0.34
▸ APOBEC3A P31941 1/20 0.33
▸ APOBEC3G Q9HC16 1/20 0.33
▸ AAK1 Q2M2I8 1/20 0.33
▸ PIM1 P11309 2/20 0.32
▸ PIM2 Q9P1W9 1/20 0.32
▸ DYRK1A Q13627 1/20 0.31
▸ GPBAR1 Q8TDU6 1/20 0.31
▸ PRKAB2 O43741 1/20 0.30
▸ PRKAG1 P54619 1/20 0.30
▸ PRKAA2 P54646 1/20 0.30
▸ PRKAA1 Q13131 1/20 0.30
▸ PRKAG3 Q9UGI9 1/20 0.30
▸ PRKAG2 Q9UGJ0 1/20 0.30
▸ PRKAB1 Q9Y478 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28903853 0.87 AAK1 (0.45) SMPD3CSNK2A1CSNK2A2AAK1DYRK1A
SCHEMBL23931661 0.82 SMPD3 (0.35) SMPD3CSNK2A1CSNK2A2APOBEC3AAPOBEC3G
SCHEMBL23931659 0.82 SMPD3 (0.38) SMPD3CSNK2A1CSNK2A2APOBEC3AAPOBEC3G
SCHEMBL23931621 0.79 SMPD3 (0.39) SMPD3CSNK2A1CSNK2A2APOBEC3AAPOBEC3G
SCHEMBL23931622 0.78 SMPD3 (0.37) SMPD3CSNK2A1CSNK2A2APOBEC3AAPOBEC3G
SCHEMBL29660252 0.78 AAK1 (0.42) SMPD3CSNK2A1CSNK2A2APOBEC3AAPOBEC3G
SCHEMBL29660281 0.76 AAK1 (0.43) SMPD3CSNK2A1CSNK2A2APOBEC3AAPOBEC3G
SCHEMBL31677677 0.71 AAK1 (0.48) SMPD3AAK1PIM1
SCHEMBL20081018 0.70 AAK1 (0.50) SMPD3AAK1
SCHEMBL29660254 0.68 AAK1 (0.56) SMPD3CSNK2A1AAK1GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427045-A 4- (3- (pyridin-3-yl) pyrazolo [1,5-a ] pyrimidin-5-yl) piperazine for the treatment of COV-229E or COV-OC43 coronavirus infection 莱西肯医药有限公司 2022-12-02 — — CN disclosed
Send feedback